Total Funding
85
62
Total FundingSeries C raised
Growth Score 85 in past quarter
-3 pts
Heat Score 62 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
37317
Animol Discovery is a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.
- Philip Austin: Co-founder
About the Company
Animol is building its own pipeline of breakthrough proprietary veterinary small molecules led by a team of animal health industry experts with vast experience in bringing drugs to market. With our unique and powerful technology platform, we deliver innovative medicines that are specifically designed for the needs of veterinary patients.